These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24172256)

  • 1. Treatment A) lifestyle modification: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2013; 20(12):835-49. PubMed ID: 24172256
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2013; 20(12):850-60. PubMed ID: 24335039
    [No Abstract]   [Full Text] [Related]  

  • 3. Women. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2014; 21(4):291-5. PubMed ID: 24335044
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2013; 20(7):603-15. PubMed ID: 23883545
    [No Abstract]   [Full Text] [Related]  

  • 5. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.
    Kinoshita M; Yokote K; Arai H; Iida M; Ishigaki Y; Ishibashi S; Umemoto S; Egusa G; Ohmura H; Okamura T; Kihara S; Koba S; Saito I; Shoji T; Daida H; Tsukamoto K; Deguchi J; Dohi S; Dobashi K; Hamaguchi H; Hara M; Hiro T; Biro S; Fujioka Y; Maruyama C; Miyamoto Y; Murakami Y; Yokode M; Yoshida H; Rakugi H; Wakatsuki A; Yamashita S;
    J Atheroscler Thromb; 2018 Sep; 25(9):846-984. PubMed ID: 30135334
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes mellitus. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2014; 21(2):93-8. PubMed ID: 24335040
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2014; 21(2):86-92. PubMed ID: 24335038
    [No Abstract]   [Full Text] [Related]  

  • 8. Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2014; 21(2):82-5. PubMed ID: 24335037
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2013; 20(10):733-42. PubMed ID: 23892529
    [No Abstract]   [Full Text] [Related]  

  • 10. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.
    Teramoto T; Sasaki J; Ueshima H; Egusa G; Kinoshita M; Shimamoto K; Daida H; Biro S; Hirobe K; Funahashi T; Yokote K; Yokode M
    J Atheroscler Thromb; 2007 Apr; 14(2):45-50. PubMed ID: 17485887
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk factors of atherosclerotic diseases. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese.
    Teramoto T; Sasaki J; Ueshima H; Egusa G; Kinoshita M; Shimamoto K; Daida H; Biro S; Hirobe K; Funahashi T; Yokote K; Yokode M
    J Atheroscler Thromb; 2007 Dec; 14(6):267-77. PubMed ID: 18176013
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosis of atherosclerosis. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2014; 21(4):296-8. PubMed ID: 24335045
    [No Abstract]   [Full Text] [Related]  

  • 13. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2013; 20(6):517-23. PubMed ID: 23665881
    [No Abstract]   [Full Text] [Related]  

  • 14. [Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice].
    Royo-Bordonada MÁ; Armario P; Lobos Bejarano JM; Pedro-Botet J; Villar Alvarez F; Elosua R; Brotons Cuixart C; Cortés O; Serrano B; Cammafort Babkowski M; Gil Núñez A; Pérez A; Maiques A; de Santiago Nocito A; Castro A; Alegría E; Baeza C; Herranz M; Sans S; Campos P;
    Hipertens Riesgo Vasc; 2017; 34(1):24-40. PubMed ID: 28017552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.
    Teramoto T; Sasaki J; Ueshima H; Egusa G; Kinoshita M; Shimamoto K; Daida H; Biro S; Hirobe K; Funahashi T; Yokote K; Yokode M;
    J Atheroscler Thromb; 2007 Aug; 14(4):155-8. PubMed ID: 17827859
    [No Abstract]   [Full Text] [Related]  

  • 16. [Healthy lifestyle protects the cardiovascular system. We know it!].
    Hellénius ML
    Lakartidningen; 2012 Sep 5-11; 109(36):1532-3. PubMed ID: 23016234
    [No Abstract]   [Full Text] [Related]  

  • 17. The cardiovascular prevention and lifestyle quiz for cardiologists.
    De Sutter J; Conraads VM
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S8-10. PubMed ID: 19675443
    [No Abstract]   [Full Text] [Related]  

  • 18. [Essence of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version and Treatment Guide for Dyslipidemia 2013--Current Strategy for the Lipid Assessment].
    Arai H
    Rinsho Byori; 2014 Sep; 62(9):878-83. PubMed ID: 27526533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.
    Okamura T; Tsukamoto K; Arai H; Fujioka Y; Ishigaki Y; Koba S; Ohmura H; Shoji T; Yokote K; Yoshida H; Yoshida M; Deguchi J; Dobashi K; Fujiyoshi A; Hamaguchi H; Hara M; Harada-Shiba M; Hirata T; Iida M; Ikeda Y; Ishibashi S; Kanda H; Kihara S; Kitagawa K; Kodama S; Koseki M; Maezawa Y; Masuda D; Miida T; Miyamoto Y; Nishimura R; Node K; Noguchi M; Ohishi M; Saito I; Sawada S; Sone H; Takemoto M; Wakatsuki A; Yanai H
    J Atheroscler Thromb; 2024 Jun; 31(6):641-853. PubMed ID: 38123343
    [No Abstract]   [Full Text] [Related]  

  • 20. [Guidelines for the management of atherosclerotic diseases in diabetes mellitus].
    Kotake H; Oikawa S
    Nihon Rinsho; 2006 Nov; 64(11):2074-80. PubMed ID: 17087299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.